Inactive Instrument

Lucira Health, Inc.

LHDX

US54948U1051

U.S. FDA authorises Lucira's home test for flu and COVID-19

February 27, 2023 at 08:13 am EST

Feb 27 (Reuters) - Lucira Health said on Monday the U.S. Food and Drug Administration had granted emergency use authorization for its combination diagnostic test for COVID-19 and flu for over-the-counter use at home. (Reporting by Bhanvi Satija in Bengaluru; Editing by Shailesh Kuber)

Latest news about Lucira Health, Inc.

Lucira Health, Inc. Went Out of Business	23-10-04	CI
Anebulo Pharmaceuticals Appoints Daniel George as Part-Time Finance Chief	23-09-29	MT
Lucira Health, Inc. Announces Board and Executive Changes	23-09-25	CI
Lucira Health, Inc. Announces Erik T. Engelson, Chief Executive Officer Resigned from the Position	23-09-25	CI
Lucira Health, Inc. Announces Richard Narido, Chief Financial Officer Resigned from the Position	23-09-25	CI
First Amended Liquidation Plan Approved for Lucira Health, Inc.	23-09-19	CI
First Amended Liquidation Plan Filed by Lucira Health, Inc.	23-09-13	CI
Modified Disclosure Statement Approved on Interim Basis for Lucira Health, Inc.	23-07-28	CI
First Motion for Exclusivity Period Extension Approved For Lucira Health, Inc.	23-07-10	CI
First Motion for Exclusivity Period Extension Filed by Lucira Health, Inc.	23-06-22	CI
Liquidation Plan and Disclosure Statement Filed by Lucira Health, Inc.	23-06-07	CI
Pfizer Inc. acquired Substantially All of the Assets of Lucira Health, Inc.	23-04-19	CI
Motion for Asset Sale Approved for Lucira Health, Inc.	23-04-19	CI
Aditxt's Pearsanta Unit Selected as Backup Bidder to Acquire Lucira Health's Assets	23-04-17	MT
Aditxt Says Unit Pearsanta Submitted Bid to Acquire All of Lucira Health Assets	23-04-17	CI
North American Morning Briefing : Stock Futures -3-	23-04-13	DJ
Asset Purchase Agreement Filed by Lucira Health, Inc.	23-04-12	CI
Pfizer Inc. entered in to an auction to acquire Substantially All of the Assets of Lucira Health, Inc. for $36.4 million.	23-04-09	CI
North American Morning Briefing : Further Caution -2-	23-04-06	DJ
Motion for Asset Sale Approved for Lucira Health, Inc.	23-04-05	CI
Bidding Procedure Approved for Lucira Health, Inc.	23-03-27	CI
Motion for Asset Sale Approved for Lucira Health, Inc.	23-03-24	CI
Lucira Health, Inc.(OTCPK:LHDX.Q) dropped from NASDAQ Composite Index	23-03-03	CI
Motion for Asset Sale Filed by Lucira Health, Inc.	23-03-02	CI
Lucira Health, Inc.(NasdaqGS:LHDX) dropped from S&P TMI Index	23-02-28	CI

Chart Lucira Health, Inc.

Duration

Period

More charts

Company Profile

Lucira Health, Inc. is a United States-based company. The Company has no business operations and is in liquidation.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+180.51%	8.67B
CHURCHILL CAPITAL CORP VII	+2.29%	983M
APPLE ISPORTS GROUP, INC.	+41.91%	883M
PERELLA WEINBERG PARTNERS	+26.17%	825M
ARES ACQUISITION CORPORATION II	+1.92%	665M
E7 GROUP	+7.72%	664M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+7.78%	530M
CAPITOL INVESTMENT CORP. VII	-.--%	500M

Shell Companies